Martin Kuiper Principal Investigator

Development of enabling technology: produce tools and approaches that allow biologists to analyse their data.

Education: 

MSc: State University Groningen, Netherlands, Main area: Biology; second area: Organic chemistry

PhD study: State University Groningen, Faculty of Medicine.

Biography: 

Martin Kuiper graduated in Molecular Biology and Organic Chemistry in 1982, and obtained a PhD degree (1987) in Biology from the University of Groningen, Netherlands. A nomadic post-doctoral existence led him though many grants and jobs, allowing him to visit virtually all of the Kingdoms of Nature. Among others he was a doctoral fellow of the Ohio State University, US (1987) and Utrecht University, Netherlands (1989). He then switched gears to join industry and worked at Keygene n.v., a molecular marker technology provider in the Netherlands; GenScope/Celera West, a Belgian subsidiary of the USA based company Celera (developing human marker and gene expression technology); and Aventis Cropsciences, a Belgian-based agrochemical biotechnology company). After 9 years in industry he joined the VIB institute in Gent, Belgium, as PI in Computational Biology. He transferred to the Norwegian University of Science and Technology in 2008, where he now works as Professor in Systems Biology. His research interests include the development of approaches and tools for analysis of biological data, the use of ontologies and semantic web technologies for the integration of biological knowledge, and the assembly of knowledge in Prior Knowledge Networks and Logical models.

Research Interests:

His research interests include the development of approaches and tools for the analysis of biological data, and the use of ontologies and semantic web technologies for the integration of biological knowledge (www.biogateway.eu). In particular, he contributed to the development of the Cytoscape platform (www.cytoscape.org), with the BioGateway App and the popular plugin BiNGO. He is now focusing on the generation of a Knowledge Commons for the Life Sciences, and together with his NTNU colleague Astrid Lægreid he leads the Gene Regulation Consortium GRECO (www.theGRECO.org), a global initiative to curate and annotate all knowledge pertaining to gene regulation in all organisms. In the DrugLogics project he uses curated knowledge for building logical models of molecular mechanisms of different cancer types and inflammation-based diseases that allow the use of in silico simulations to predict effects of chemical inhibitors/drugs.

For publications, please see my Google Scholar site